Compounds and compositions as protein kinase inhibitors

摘要

The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders than involve abnormal activation of the Abl, Bcr-abl, Bmx, c-RAF, CSK, Fes, FGFR3, Flt3, GSK3beta, IR, JNK1alpha 1, JNK2alpha 2, Lck, MKK4, MKK6, p70S6K, PDGFRalpha, Rsk1, SAPK2alpha, SAPK2beta, Syk and Trkbeta kinases.